ResMed was named in a patent infringement lawsuit on Nov. 5 in Delaware District Court over its home sleep testing technologies. The action, brought by Potter Anderson & Corroon and Herbert Smith ...

Abstract: Multispectral object detection, which combines RGB visible light and thermal infrared spectral information, has broad applications in complex environments and varying illumination conditions ...

Fintel reports that on November 3, 2025, Baird maintained coverage of ResMed (NYSE:RMD) with a Outperform recommendation. Analyst Price Forecast Suggests 20.94% Upside As of October 30, 2025, the ...

Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above ...

Oct. 30, 2025 10:17 PM ETResMed Inc. (RMD) Stock, RSMDF StockAI-Generated Earnings Calls Insights ...

ResMed Inc (ASX: RMD) shares are ending the week on a positive note. At the time of writing, the sleep disorder treatment company's shares are up 2.5% to $39.90. This follows the release of the ...

SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Thursday reported fiscal first-quarter net income of $348.5 million. On a per-share basis, the San Diego-based company said it had net income of ...

Abstract: Accurate tree crown delineation from very high-resolution UAV orthophotos in urban areas remains challenging due to landscape complexity and the scarcity of representative annotated data.